Email this article Criteria for the definitive diagnosis of melanoma, by creation of a scorecard
- Authors: Yargunin S.A1, Davidenko I.S1
-
Affiliations:
- Clinical Oncological Center No1 of Health Department of Krasnodar Region
- Issue: Vol 18, No 3 (2013)
- Pages: 49-52
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40011
- DOI: https://doi.org/10.17816/onco40011
- ID: 40011
Cite item
Full Text
Abstract
Melanoma of a skin is thought to be one of the most aggressive tumors with unpredictable prognosis because of a high potency of local growth, local and remote metastases, and dissemination. Regarding this point very important aspect is an adequate assessment of patients and proper therapy administration according to a disease stage. Options for effective diagnosis is to create a single user registration card will allow to create the uniform Russian Federation register of patients with a skin melanoma and will help to introduce an international treatment standard with distribution of patients on stages and substages.
Full Text
##article.viewOnOriginalSite##About the authors
S. A Yargunin
Clinical Oncological Center No1 of Health Department of Krasnodar Region
Email: sdocer@rambler.ru
канд. мед. наук, зав. отд-нием хирургии опухолей кожи и мягких тканей
I. S Davidenko
Clinical Oncological Center No1 of Health Department of Krasnodar Region
Email: newfolder@mail.ru
заведующая отделением химиотерапии, доктор медицинских наук
References
- Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2007 г Вестник РОНЦ им. Н.Н. Блохина. 2009; 20( 3): 2.
- Мерабишвили В.М., Чепик О. Ф. Анализ выживаемости и погодичной летальности больных злокачественной меланомой кожи на популяционном уровне. Вопросы онкологии. 2006; 52 (4): 385-91.
- Allen D.C. Histopathology reporting. 2-nd Ed. ; 2006: 200-9.
- Balch C.M. Cutaneous melanoma: prognosis and treatment results worldwide. Semin. Surg. Oncol. 1992; 8: 400-14.
- Balch C.M., SoongS.J., Murad T.M. et al. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann. Surg. 1981; 193: 377-88.
- Batistatou A., Cook M.G., Massi D. Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology. Virchows Arch. 2009; 454 (5): 505-11.
- Buzaid A.C., Ross M.I., Balch C.M. et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J. Clin. Oncol. 1997; 15: 1039-51.
- Carli P. et al. Campagna per la diagnosis precode del melanoma. Quanto e efficace lazione di ''filtro'' del medico di famiglia? G. Ital. Dermatol. Venereol. 1998; 133( 6): 405-10.
- Clark W.H., Elder D.E., Guerry D. et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 1989; 81: 1893-904.
- Compton C.C., Barbill R., Wick M.R., Balch C. Protocol for the examination of specimen from patients with melanoma of the skin. Arch. Pathol. Lab. Med. 2003; 127: 1253-60.
- Rivers J.K. Melanoma. Lancet. 1996; 347: 803-7.
Supplementary files
